What you should know:
1. The guideline, published in Gastroenterology, navigates the increased number of therapies available for the long-term management of moderate to severe ulcerative colitis.
2. The guideline focuses on immunomodulators, biologics and small molecules that lead to remission and decrease colectomy risk.
3. There is no cure for UC, but quality of life increases when the disease is in remission.
Read the entire guideline here.
More articles on surgery centers:
Nevada city drops ASC building acquisition to let health system buy it
Insights from the CEOs of Optum, USPI, Surgery Partners & more — 8 ASC industry notes
Why Texas’ ASC market is booming — 4 center leaders elaborate
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
